448 Protein Structure, Function, and Stability II

Wednesday, October 31, 2012: 8:30 AM
Washington (Westin )
Description:
We invite submissions pertaining to protein structure, function, and stability. Studies may include structural or functional analysis, engineering of new proteins, analysis of protein conformational and colloidal stability, mechanisms of protein folding and misfolding, and mechanisms of protein degradation via physical and chemical routes. Reports relevant to other biotechnological products are also welcome.

Sponsor:
Bioengineering

Chair:
Joel L. Kaar
Email: joel.kaar@colorado.edu

Co-Chair:
Michelle A. O'Malley
Email: momalley@engineering.ucsb.edu


8:30 AM
(448a) Effect of Histone Tail Modifications On Chromosome Structure and Activity
Nate Nurse and Chongli Yuan

8:48 AM
(448h) A Zipper-Like Mechanism Steers the Recognition of Cyanobacterial Split Inteins
Mirco Sorci, Bareket Dassa, Shmuel Pietrokovski, Marlene Belfort and Georges Belfort

9:06 AM
(448c) Forcefield Ptm: Development and Testing of a First Generation AMBER Forcefield for Post-Translational Modifications
George A. Khoury, Jeff P. Thompson and Christodoulos A. Floudas

9:24 AM
(448d) Alterations in Endothelial Barrier Function Differentially Regulate the Transport of Adiponectin Oligomers
Joseph M. Rutkowski and Philipp E. Scherer

9:42 AM
(448e) Structural and Functional Characterization of Photosynthetic Proteins in Marine Algae
Jing Jiang, Hao Zhang, Robert Blankenship and Cynthia S. Lo

10:00 AM
(448f) NMR Characterization of an Engineered Allosteric Enzyme
Abigail H. Laurent, Yuchao Chen, Luke Arbogast, Jason Labonte, Ananya Majumdar, Jeffrey J. Gray, Joel Tolman and Marc Ostermeier

10:18 AM
(448g) Biophysical Characterization of Mutated Fiber Adenoviruses
Grit Kupgan and Joshua Ramsey

10:36 AM
(448b) Acyl Carrier Protein Structural Classification and Normal Mode Analysis
David C. Cantu, Michael J. Forrester, Katherine Charov and Peter J. Reilly
See more of this Group/Topical: Food, Pharmaceutical & Bioengineering Division - See also TI: Comprehensive Quality by Design in Pharmaceutical Development and Manufacture
<< Previous Session | Next Session >>